Literature DB >> 8019851

Mycoplasma triggering of nitric oxide production by central nervous system glial cells and its inhibition by glucocorticoids.

T Brenner1, A Yamin, R Gallily.   

Abstract

The same cytokines that have been implicated in the pathology of central nervous system (CNS) inflammatory diseases and demyelinating diseases are also associated with the induction of nitric oxide (NO) production by macrophages and other somatic cells. Recently we have showed that mycoplasma can trigger the production of tumor necrosis factor (TNF)alpha and eicosanoids in rat astrocytes. In the present study, the effect of mycoplasma on NO production in rat glial cells was assessed. The addition of 10 micrograms/ml of membranes derived from M. capricolum (sheep isolate), M. fermentans (human isolate), or lipopolysaccharide (LPS) led to a 15- to 20-fold increase in NO production. The glucocorticoids dexamethasone and corticosterone, but not progesterone, markedly inhibited NO production. The addition of glucocorticoid prior or conjointly with the activator prevented large amounts of NO from being formed. Even when glucocorticoids were added 5 or 24 h after activation, effective inhibition of NO production was obtained. Thus, it is likely that glucocorticoids exert some of their ameliorating effects in neurological diseases by reducing the production of NO, cytokines and prostaglandins in the CNS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8019851     DOI: 10.1016/0006-8993(94)91814-7

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  cDNA and genomic cloning and expression of the P48 monocytic differentiation/activation factor, a Mycoplasma fermentans gene product.

Authors:  R E Hall; S Agarwal; D P Kestler; J A Cobb; K M Goldstein; N S Chang
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

2.  Mycoplasma fermentans-induced inflammatory response of astrocytes: selective modulation by aminoguanidine, thalidomide, pentoxifylline and IL-10.

Authors:  R Gallily; M Kipper-Galperin; T Brenner
Journal:  Inflammation       Date:  1999-12       Impact factor: 4.092

3.  [Fulminant meningoencephalitis associated with Mycoplasma pneumoniae infection in adults. Aggressive treatment enabled a good outcome].

Authors:  Roland Sparing; Christoph Spitzer; Helga Häfner; Dirk Zolldann; Marcus H T Reinges; Timo Krings; Johannes Noth; Christoph M Kosinski
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

4.  Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury.

Authors:  Jin-Moo Lee; Ping Yan; Qingli Xiao; Shawei Chen; Kuang-Yung Lee; Chung Y Hsu; Jan Xu
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

Review 5.  Molecular biology and pathogenicity of mycoplasmas.

Authors:  S Razin; D Yogev; Y Naot
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

6.  Frequent detection of Mycoplasma pneumoniae in Bell's palsy.

Authors:  C Völter; J Helms; B Weissbrich; P Rieckmann; M Abele-Horn
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-10-24       Impact factor: 2.503

7.  N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties.

Authors:  Garry Milman; Yehoshua Maor; Saleh Abu-Lafi; Michal Horowitz; Ruth Gallily; Sandor Batkai; Fong-Ming Mo; Laszlo Offertaler; Pal Pacher; George Kunos; Raphael Mechoulam
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-07       Impact factor: 11.205

Review 8.  Alcohol and the brain: what's NO got to do with it?

Authors:  F E Lancaster
Journal:  Metab Brain Dis       Date:  1995-06       Impact factor: 3.584

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.